Home » Topics » Disease categories and therapies » Immune

Immune
RSS

BTG licenses anti-CD3 antibody to LeukoSite

March 15, 1999

FDA grants fast track designation for pneumococcal conjugate vaccine

March 12, 1999

Zenapax shows positive results in GVHD trial

March 10, 1999

North American Vaccine adds new product to R&D pipeline; U.S. patent issues

March 8, 1999

Licensing opportunity from BTG: fatty acid-peptide conjugates for use in vaccines

March 5, 1999

Epicoat technology granted U.S. patent protection

March 5, 1999

Roche obtains European marketing approval for transplant drug

March 4, 1999

Novel vaccine technology available for licensing from BTG

March 4, 1999

Praxis purchases intellectual property allowing development of antirejection drug

March 4, 1999

Cerus cleared by FDA to begin clinical trials of transplantation system

March 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...